Component information
No US or EU label exists for this exact combination, so information is shown for each component.
- metformin hci no separate page
Use: Type 2 diabetes (monotherapy, with metformin, a glitazone or insulin) renalcarematters.com, reviewed
Kidney dosing: Vildagliptin (single-agent)Show full dosing details
- CrCl ≥60 mL/min
- Usual dose: 50 mg twice daily (100 mg/day); 50 mg once daily in the morning when combined with a sulfonylurea. Maximum 100 mg/day (SmPC).
- CrCl 30–59 mL/min
- CrCl ≥50: no adjustment (50 mg twice daily). CrCl <50 (moderate impairment): 50 mg once daily (SmPC).
- CrCl 15–29 mL/min
- Severe impairment: 50 mg once daily (SmPC).
- CrCl <15 mL/min (not on dialysis)
- Severe impairment: 50 mg once daily (SmPC).
- Hemodialysis (intermittent)
- ESKD on hemodialysis: 50 mg once daily; experience is limited, so use with caution (SmPC). About 3% removed by hemodialysis; timing relative to dialysis not critical.
- Peritoneal dialysis
- SmPC dose for ESKD (50 mg once daily) does not specify modality; no peritoneal dialysis data.
- CRRT
- No data in the SmPC. Glucose control in critical illness is usually with insulin.
- Dialyzable? Minimally: about 3% removed by hemodialysis; the main inactive metabolite (LAY 151) is removed (SmPC 5.2).
- Monitoring Liver function tests before starting, every 3 months in the first year and periodically thereafter; stop if aminotransferase stays at 3 times the upper limit of normal or more (SmPC 4.4). Watch for pancreatitis, bullous skin lesions and hypoglycemia with a sulfonylurea or insulin.
From the Vildagliptin monograph (renalcarematters.com, reviewed).
Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.
Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney dosing for each component (single-agent) is shown under Component information.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Film-coated tablet: 50 mg + 1 g, 50 mg + 500 mg, 50 mg/1 g, 50 mg/500 mg, 50 mg/850 mg
Registered products in the Philippines
6 products registered with the Food and Drug Administration (FDA) Philippines list Metformin hci + Vildagliptin as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
All registered products6
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
Alvovilda MetVildagliptin + Metformin HCI | 50 mg/1 g Film-coated TabletAlu/Alu Blister Pack x 6's (Box of 30's) | Rx | Intas Pharmaceuticals Limited.India | Metro Drug, Inc. | DRP-15391 | Jul 8, 2029 | |
Alvovilda MetVildagliptin + Metformin HCI | 50 mg/850 mg Film-coated TabletAlu/Alu Blister Pack x 6's (Box of 30's) | Rx | Intas Pharmaceuticals Limited.India | Metro Drug, Inc. | DRP-15392 | Jul 8, 2029 | |
Gilda MetVildagliptin + Metformin HCI | 50 mg + 1 g Film-Coated TabletAlu/Alu Blister Pack X 10's (Box of 30's) | Rx | Lloyd Laboratories Inc.Philippines | Trader: Aldril Pharmaceuticals, Inc. | DRP-18274 | Jun 4, 2031 | |
GildaGen-MVildagliptin + Metformin HCI | 50 mg + 1 g Film-Coated TabletAlu/Alu Blister Pack X 10's (Box of 30's) | Rx | Lloyd Laboratories Inc.Philippines | Trader: Innogen Pharmaceuticals, Inc. | DRP-18325 | Jun 15, 2032 | |
GildaGen-MVildagliptin + Metformin HCI | 50 mg + 500 mg Film-Coated TabletAlu/Alu Blister Pack X 10's (Box of 30's) | Rx | Lloyd Laboratories Inc.Philippines | Trader: Innogen Pharmaceuticals, Inc. | DRP-18326 | Jun 15, 2032 | |
HealusmetVildagliptin + Metformin HCI | 50 mg/500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's) | Rx | Korea United Pharm. Inc.Korea | United Douglas Pharm Philippines Inc. | DRP-16678 | Jun 4, 2030 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Formulary and pricing (Philippines)
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .